In routine surveillance and diagnostic testing, influenza virus samples are typically collected only from the upper respiratory tract (URT) due to the invasiveness of sample collection from the lower airways. Very little is known about virus variation in the lower respiratory tract ( 
Abstract
In routine surveillance and diagnostic testing, influenza virus samples are typically collected only from the upper respiratory tract (URT) due to the invasiveness of sample collection from the lower airways. Very little is known about virus variation in the lower respiratory tract (LRT) and it remains unclear if the virus populations at different sites of the human airways may develop to have divergent genetic signatures. We used deep sequencing of serially obtained matched nasopharyngeal swabs and endotracheal aspirates from four mechanically ventilated patients with influenza A/H3N2 infections. A physical barrier separating both compartments of the respiratory tract introduced as part of the medical procedures enabled us to track and compare the genetic composition of the virus populations during isolated evolution in the same host. Amino acid variants reaching majority proportions emerged during the course of infection in both nasopharyngeal swabs and endotracheal aspirates, and amino acid variation was observed in all influenza virus proteins. Genetic variation of the virus populations differed between the URT and LRT and variants were frequently uniquely present in either URT or LRT virus populations of a patient. These observations indicate that virus populations in spatially distinct parts of the human airways may follow different evolutionary trajectories. Selectively sampling from the URT may therefore fail to detect potentially important emerging variants.
Importance
Influenza viruses are rapidly mutating pathogens that easily adapt to changing environments.
Although advances in sequencing technology make it possible to identify virus variants at very low proportions of the within-host virus population, several aspects of intrahost viral evolution have not been studied because sequentially collected samples and samples from the lower respiratory tract are not routinely obtained for influenza surveillance or clinical diagnostic purposes.
Introduction

11
Influenza A viruses are genetically variable due to the low fidelity of the influenza virus RNA 12 polymerase and can therefore quickly evolve in response to changing environments and selection 13 pressures, leading to escape from natural or vaccine-induced immunity, antiviral drug resistance 14 and adaptation to new hosts. Intrahost influenza virus populations are genetically heterogeneous 15 and consist of closely related but diverse virus variants. The evolution of influenza viruses has 16 been studied in much detail at population levels on a global scale, but the intrahost evolutionary 17 processes that are fundamental to emergence of new variants in the human population are less 18 well understood. appeared to behave as independent virus populations based on aerosol shedding of human 28 volunteers (4). Although these studies provide clues that virus populations in spatially separated 29 compartments of the respiratory tract may evolve independently, current insights into potential 30 differences in genetic composition and evolution of virus populations between URT and LRT 31 compartments remain incomplete. 32
33
Improved understanding would ideally require analyses of serial specimens collected in parallel 34 from both respiratory compartments during the course of influenza, the feasibility of which is 35 challenging due to the invasiveness of such sampling. We had an opportunity to perform such 36 analyses in four influenza A/H3N2 virus-infected patients who participated in a study of the 37 prevalence and shedding patterns of respiratory viruses in critically ill patients receiving 38 mechanical ventilation (5, 6). For the purpose of this study, nasopharyngeal specimens and 39 endotracheal aspirates were collected each day from patients while intubated and ventilated. 40
Endotracheal tubes used for mechanical ventilation contain a balloon cuff designed to provide a 41 seal inside the trachea that allows airflow through the tube whilst preventing passage of air or 42 fluids around it. Importantly, this feature allowed analysis of virus populations in upper and lower 43 respiratory tract compartments in isolation. Using a next generation sequencing approach, virus 44 patient W). However, consistent outgrowth during sampling was observed only for NS1 H59L, 79 whereas the variant proportions of HA G5E and NS1 L185F dropped below the detection limit 80 within days after reaching majority. We could not determine evolutionary patterns for the duration 81 of infection for NA E76D because the coverage of this genetic region was below our inclusion 82 threshold for three out of five days. the first day of sample collection. Variants that met our inclusion criteria and that were unique to 93 either NPS or ETA were observed in all four patients, albeit at moderate proportions. Variants 94 present in both NPS and ETA similarly showed moderate differences in variant proportions 95 between NPS and ETA samples. Because our analysis of temporal differences in variant 96 proportion indicated that the virus populations in these patients evolved over time, we repeated 97 the analysis using for each patient the samples collected at the last time point where influenza 98 virus-positive NPS and ETA were available (Fig. 3 panels C and D) . Also here, variant proportions 99 in the NPS and ETA were genetically different in all patients, and included variants that were 100 present in only one airway compartment. These results show that the genetic composition of the 101 virus populations in NPS and ETA was different during identical periods after intubation in all four 102
patients. 103 104
The analysis of differences between the virus populations in NPS and ETA revealed a number of 105 notable variants. Two of the four variants that reach majority proportions, HA G5E and NA E76D, 106 were uniquely observed in the NPS of patients X and Y, respectively (Figs. S3 and S4) . The 107 remaining two variants that reach majority proportions, NS1 H59L and NS1 L185F, reach peak 108 variant proportions while being undetectable in the other airway compartment at matched time 109
points. In addition, these variants were present and continued to vary in proportion in ETA after 110 the virus became undetectable in NPS, as was also the case for HA N144K ( groups have now used deep sequencing approaches to determine the genetic variation of human 121 influenza A viruses in patient-derived materials. These studies have mostly focused on variation 122 in relation to immune escape because of the major role of this process in influenza virus evolution 123 (7-9), or on better understanding transmission bottlenecks and stringency of intrahost selection 124 pressures (10-12). The scarcity of sequentially collected clinical specimens accessible for 125 scientific purposes, particularly those obtained from the lower respiratory tract, has limited the 126 opportunities for studying the temporal genetic variation of within-host influenza virus populations 127 (9, 13, 14). Here we had the opportunity to study intrahost viral genetic variation in longitudinally 128 collected nasopharyngeal swabs and endotracheal aspirates of individuals in whom upper and 129 lower airway compartments were separated by a physical barrier due to mechanical ventilation. 130
We evaluated the intrahost evolutionary patterns of influenza A/H3N2 virus in both airway 131 compartments and compared the genetic composition of the virus populations in the upper and 132 lower airways . 133
134
Our results indicate intrahost viral genetic diversity and temporal differences in the composition of 135 the virus populations in the URT and in the LRT of all patients. The modest number of variants 136 observed in each patient is in concordance with previous studies that reported limited genetic 137 variation based on studies using single time points (7, 8, 10) . Nonetheless, we observed outgrowth 138 of several variants towards or above majority proportions, often reaching peak proportions within 139 a week after the start of sample collection. Our data also point out that variants may reach majority 140 proportions in both airway compartments. These outcomes suggest that substantial genetic 141 changes in the influenza A virus populations of the URT and LRT can take place during the short 142 time periods typical of transient influenza virus infections. 143 7 compartments of the patients included in this study. Our finding that distinct viral genotypes 147 frequently existed in one but not the other airway compartment complements a recent study that 148 demonstrated spatial separation of the virus populations in humans without the mechanical barrier 149 that was present in the patients sampled for the current study (4). That work showed that humans 150 generate infectious aerosols that represent infection of the LRT and that viral load in URT samples 151 poorly predicted shedding of virus in aerosols. Here we show that virus populations in distal parts 152 of the human airways were composed of distinct viral genotypes that followed isolated evolutionary 153 pathways. If aerosols support influenza virus transmission, the results of the current study imply 154 that variants originating from the lower airways may contribute to long-term (interhost) virus 155 evolution. The differences between genetic compositions of virus populations in the URT and LRT, 156 even during matched time points, suggests that genetic analysis of the virus population in URT 157 samples is a poor proxy for genetic variation in the LRT virus population. Given that current 158 sampling regimens rarely include sample collection from the LRT, a potentially important 159 evolutionary setting may be almost entirely unexplored. 160
161
While it is plausible that the distinct physiological conditions and receptor distributions in the URT 162 and LRT gives rise to site specific variants, identification of adaptive amino acid changes resulting 163 from selection pressures specific to either compartment was precluded by the limited number of 164 patients in this study. However, HA N144K, HA R229K, NA V251I, and NS1 L185F have been 165 associated with antibody evasion or immune modulation (15) (16) (17) (18) (19) (20) , which may explain the rapid 166 increase in variant proportion of some of these variants. Our findings are in agreement with 167 previous results that reported limited variation on amino acid positions associated with immune 168 escape (7-9, 12), and studies that suggested that antigenic adaptation is unlikely to be a major 169 mechanism responsible for intrahost genetic variation (8). Additionally, truncation of M2 at position 170 77 was shown to have no impact on ion-channel activity (21), suggesting that this amino acid 171 variation may also have been phenotypically neutral in the viruses observed in this study. The 172 phenotypic effects of other notable variants, including those reaching majority proportions, have 173 to our knowledge not been reported. 174
175
In summary, we showed disparate evolution of virus populations in spatially separated parts of the 176 human airways following natural infection with a seasonal human influenza virus. The temporal 177 variability and genetic differences between intrahost virus populations puts into question thesurveillance, and of studies into influenza disease and virus evolution. This is especially true for 181 studies looking into intrahost genetic diversity using deep sequencing approaches. 182
Patients and samples 185
The samples used in this study were collected as part of a multicenter prospective observational 186 study performed in The Netherlands (Dutch Trial Register NTR4102) as described previously 187 (Table S3) . For whole genome amplification we performed 20 independent PCR 207 reactions in total. Three partly overlapping amplicons were generated for the PB2, PB1, PA, HA, 208 NA and NP segments each, a single amplicon each was generated for the M and NS gene 209 segments. For each sample, PCR products were pooled in equimolar concentrations and 210 subsequently purified using Agencourt Ampure XP beads (Beckman Coulter, A63882) and 211 quantified using the Qubit dsDNA HS assay kit (ThermoFisher, Q32854). Pooled and cleanedFC-131-1096) according to manufacturer's instructions. Briefly, for each sample 5 µl of diluted 216 amplicons were enzymatically fragmented and Illumina adapters were ligated to the fragments. 217
Subsequently each sample was purified twice using Agencourt Ampure XP beads. Library size 218 distribution was evaluated using the High sensitivity dsDNA kit on a 2100 Bioanalyzer (Agilent, 219 5067-4626) and qPCR based library quantification was performed using the KAPA Library 220
Quantification kit for Illumina platforms (KAPA Biosystems, KK4824) on a LightCycler480 (Roche). 221
Normalized library pools were sequenced on an Illumina MiSeq machine using the 600-cycle 222
MiSeq Reagent Kit v3 (Illumina, MS-102-3003). All FASTQ files are available on request. 223 224
Quality control, variant detection and data analysis 225
Quality trimming of Illumina MiSeq reads was performed using the Maximum Information quality 226 filtering approach of the Trimmomatic tool (version 0.36, parameters; leading:3, trailing:3, 227 maxinfo: 80:0.4, crop:280) (25). Merging, mapping, and coverage analysis was done using the 228
BBmerge, BBwrap, and pileup scripts from the BBMap bioinformatics toolkit version 36.27 (26). 229
Read pairs with inappropriate orientation and reads with a Q-score below 25 were discarded. 230
Quality control was monitored using FastQC version v0. 11.5 (27) . 231 232 Subsequent steps were performed using a set of custom scripts (available on request). Mapped 233 reads were translated and prepared for variant calling by identification of appropriate reading 234 frames and conversion of read numbering to protein numbering for the 12 influenza A virus 235 proteins considered here; PB2 (polymerase basic 2), PB1 (polymerase basic 1), PA (polymerase 236 acidic), HA (hemagglutinin), NP (nucleoprotein), NA (neuraminidase), M1 (matrix protein 1), PA-237 X (polymerase acidic protein-X), NS1 (non-structural protein 1), NS2 (nuclear export protein), M2 238 (matrix 2 ion channel), and PB1-F2 (PB1 frame 2). HA amino acid positions in the manuscript are 239 numbered according to Burke et al. (28) . For each patient the data on coverage per position, 240 variant count, and variant proportion was collected for all time points and for URT and LRT 241 samples. Next a number of filtering steps was performed. Variants passing filter were outside of 242 primer regions, had a minimum coverage of 100x for each position in the codon, and were present 243 at at least 1% of the total virus population with a minimum of five observations per sample. All 244 variants included in our analyses were detectable in two or more samples from the same airway The influenza virus proteins analyzed for this study are basic polymerase 2 (PB2), basic polymerase 1 (PB1), acidic polymerase (PA), hemagglutinin (HA), nucleoprotein (NP), neuraminidase (NA), matrix protein 1 (M1), acidic polymerase protein X (PA-X), non-structural protein 1 and 2 (NS1, NS2), matrix protein 2 (M2), and basic polymerase 1 frame 2 (PB1-F2). A/H3N2 virus HA numbering according to Burke et al. (28) . Abbreviations: APACHE II = Acute Physiology and Chronic Health Evaluation II ; CHF = congestive heart failure; CRP = C-reactive protein; DMII = diabetes mellitus type II; ICU = intensive care unit; SAPS II = Simplified Acute Physiology Score II;
